Impact of Gene Patents and Licensing Practices on Access to Genetic Testing and Carrier Screening for Tay-Sachs and Canavan Disease

Genetics in Medicine- United States

doi 10.1097/gim.0b013e3181d5a669

Full Text

Abstract

Available in

Categories

Date

April 1, 2010

Authors

Alessandra Colaianni

Subhashini Chandrasekharan

Robert Cook-Deegan

Publisher

Springer Science and Business Media LLC

Related search

Impact of Gene Patents and Licensing Practices on Access to Genetic Testing for Alzheimer Disease

Genetics in Medicine

English

Impact of Gene Patents and Licensing Practices on Access to Genetic Testing for Long QT Syndrome

Genetics in Medicine

English

Comment on the Impact of Gene Patents and Licensing Practices on Access to Genetic Testing: Lessons From Hereditary Hemorrhagic Telangiectasia

Genetics in Medicine

English

Testing Fate: Tay-Sachs Disease and the Right to Be Responsible

Disability and Society

Health Professions

Social Sciences

English

A Genetic Screening Programme for Tay-Sachs Disease and Cystic Fibrosis for Australian Jewish High School Students

Journal of Medical Genetics

English

Tay Sachs Disease in Australia: Reduced Disease Incidence Despite Stable Carrier Frequency in Australian Jews

Medical Journal of Australia

English

Choroidal Coloboma in a Case of Tay-Sachs Disease

Case Reports in Ophthalmological Medicine

English

Enfermedad De Tay Sachs

Revista Chilena de Pediatria

English

Study of Genetics Mutations in HEXA Gene for Induced Tay-Sachs Disease in Human, Tabriz, Iran

Open Access Journal of Microbiology & Biotechnology

English